The IP Factor

Teva Pharmaceutical Industries Ltd., Israel’s largest pharmaceutical company and the world’s leading generic drug manufacturer has apparently filed a patent lawsuit against Kyowa Hakko Kogyo Co. with the Tokyo District Court.
Teva claims that the Japanese company is infringing a patent owned by Teva’s Hungarian subsidiary that relates to a method of synthesizing a cholesterol lowering drug, and is seeking a court order to force the Japanese company to destroy its supply of the drug as well as halt production and sales in Japan.

This entry was posted on Monday, January 28th, 2008 at 7:12 pm and is filed under drugs, infringement, Intellectual Property, Israel, Israel Patent, Israel Related, News, Patents, pharmaceuticals, pharmaceuticals and Biotechnology, Teva. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.